Shanghai Junshi Biosciences Co., Ltd. (SHJBF)
3.35
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 3.437B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 70.05% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | 8.951 |
| Price to Book Value | 4.027 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 1.014 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 91.68% |
Profile
| Shanghai Junshi Biosciences Co., Ltd. engages in the discovery, development, clinical research, and commercialization of biopharmaceutical drugs. The firm’s products include toripalimab injection, UBP1211, JS002, and UBP1213. It operates through the following geographical segments: Mainland China, USA, India, and Others. The company was founded by Zhuo Bing Zhang and Ji Kuan Shan on December 27, 2012 and is headquartered in Shanghai, China. |
| URL | http://www.junshipharma.com |
| Investor Relations URL | N/A |
| HQ State/Province | Shanghai |
| Sector | Health Care |
| Industry | Biotechnology |
| Equity Style | Small Cap Core |
| Next Earnings Release | Aug. 26, 2026 |
| Last Earnings Release | Aug. 26, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Shanghai Junshi Biosciences Co., Ltd. engages in the discovery, development, clinical research, and commercialization of biopharmaceutical drugs. The firm’s products include toripalimab injection, UBP1211, JS002, and UBP1213. It operates through the following geographical segments: Mainland China, USA, India, and Others. The company was founded by Zhuo Bing Zhang and Ji Kuan Shan on December 27, 2012 and is headquartered in Shanghai, China. |
| URL | http://www.junshipharma.com |
| Investor Relations URL | N/A |
| HQ State/Province | Shanghai |
| Sector | Health Care |
| Industry | Biotechnology |
| Equity Style | Small Cap Core |
| Next Earnings Release | Aug. 26, 2026 |
| Last Earnings Release | Aug. 26, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |